These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37321205)

  • 1. Atezolizumab-induced cerebellar ataxia in a patient with metastatic small cell lung cancer: A case report and literature review.
    Kapagan T; Aksu F; Yuzkan S; Bulut N; Erdem GU
    J Oncol Pharm Pract; 2024 Jan; 30(1):201-205. PubMed ID: 37321205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report.
    Yamaguchi Y; Nagasawa H; Katagiri Y; Wada M
    J Med Case Rep; 2020 Jul; 14(1):88. PubMed ID: 32620173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-Related Cerebellar Ataxia: A Rare Adverse Effect of Checkpoint Inhibitor Therapy.
    Sebbag E; Psimaras D; Baloglu S; Bourgmayer A; Moinard-Butot F; Barthélémy P; Tranchant C; Honnorat J; Bender L
    J Neuroimmune Pharmacol; 2022 Dec; 17(3-4):377-379. PubMed ID: 34687000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Cancer Wherein Durvalumab Induced Both Anti-CRMP-5 Antibody-related Paraneoplastic Neurological Syndromes and Neurological Adverse Events.
    Seki T; Baba K; Hayashi T; Furuta R; Hirosawa H; Mitsui T; Maesaka H; Takasawa S; Miwa T; Tanaka K; Nakatsuji Y
    Intern Med; 2024 Apr; 63(7):1009-1014. PubMed ID: 37612090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: immune-mediated cerebellar ataxia secondary to anti-PD-L1 treatment for lung cancer.
    Tan YY; Rannikmäe K; Steele N
    Int J Neurosci; 2019 Dec; 129(12):1223-1225. PubMed ID: 31414604
    [No Abstract]   [Full Text] [Related]  

  • 6. Anaphylactic shock in a small cell lung cancer patient receiving atezolizumab therapy: a rare but potentially fatal complication.
    Zhao Y; Peng W; Abbas M; Shi M; Tang Y; Wang L; Yan H
    Invest New Drugs; 2022 Feb; 40(1):209-214. PubMed ID: 34398354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer.
    Wang L; Lou H; Li B; Li J; Yang YM
    Invest New Drugs; 2022 Feb; 40(1):151-156. PubMed ID: 34287773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsoclonus-Ataxia Syndrome in a Patient With Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
    Farina A; Villagrán-García M; Benaiteau M; Lamblin F; Fourier A; Honnorat J; Joubert B
    Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200287. PubMed ID: 39013128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare side effect caused by atezolizumab, an immune checkpoint inhibitor: Cold agglutinin disease.
    Acikgoz O; Bayramgil A; Cavusoglu G; Sadri S
    J Oncol Pharm Pract; 2021 Dec; 27(8):2066-2068. PubMed ID: 34282980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic Opsoclonus-myoclonus Syndrome with Anti-Hu and Anti-SOX-1 Antibodies after Immune-checkpoint Inhibitor Treatment Combined with Chemotherapy in a Patient with Small-cell Lung Cancer.
    Arai H; Utsu Y; Horio J; Furukawa S; Kikkawa Y
    Intern Med; 2022; 61(1):71-74. PubMed ID: 34980760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lambert-Eaton Myasthenic Syndrome Caused by Atezolizumab in a Patient with Small-cell Lung Cancer.
    Kunii E; Owaki S; Yamada K; Yoshihara M; Yamaba Y; Takakuwa O; Toyoda T; Akita K
    Intern Med; 2022 Jun; 61(11):1739-1742. PubMed ID: 34707051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atezolizumab-induced Sclerosing Cholangitis in a patient with lung cancer: A case report.
    Nabeshima S; Yamasaki M; Matsumoto N; Takaki S; Nishi Y; Kawamoto K; Taniwaki M; Ohashi N; Hattori N
    Cancer Treat Res Commun; 2021; 26():100270. PubMed ID: 33338849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic case conference from Northwestern: an elderly gentleman with an unsteady gait.
    Vidula N; Johnson M; Didwania A
    Am J Ther; 2012 May; 19(3):199-203. PubMed ID: 22314212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer.
    Ardizzoni A; Azevedo S; Rubio-Viqueira B; Rodríguez-Abreu D; Alatorre-Alexander J; Smit HJM; Yu J; Syrigos K; Trunzer K; Patel H; Tolson J; Cardona A; Perez-Moreno PD; Newsom-Davis T
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral retrobulbar optic neuritis combined with optic perineuritis associated with atezolizumab treatment for small cell lung carcinoma.
    Zhang J; Wang L; Zhang L; Liu H; Yang B; Jiang L
    Eur J Ophthalmol; 2024 May; 34(3):NP29-NP33. PubMed ID: 38178774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-related organizing pneumonitis in non-small cell lung cancer receiving PD-1 inhibitor treatment: A case report and literature review.
    Yin B; Xiao J; Li J; Liu X; Wang J
    J Cancer Res Ther; 2020; 16(7):1555-1559. PubMed ID: 33565499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study.
    Fonseca E; Cabrera-Maqueda JM; Ruiz-García R; Naranjo L; Diaz-Pedroche C; Velasco R; Macias-Gómez A; Milisenda JC; Muñoz-Farjas E; Pascual-Goñi E; Gállego Perez-Larraya J; Saiz A; Dalmau J; Blanco Y; Graus F; Martinez-Hernandez E;
    Lancet Neurol; 2023 Dec; 22(12):1150-1159. PubMed ID: 37977714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atezolizumab-induced subacute cerebellar ataxia in a patient with extensive-stage small cell lung cancer.
    Chen CC; Tseng KH; Lai KL; Chiang CL
    Ther Adv Med Oncol; 2023; 15():17588359231192398. PubMed ID: 37667780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: a case report.
    Yamakawa H; Oba T; Ohta H; Tsukahara Y; Kida G; Tsumiyama E; Nishizawa T; Kawabe R; Sato S; Akasaka K; Amano M; Kuwano K; Matsushima H
    BMC Pulm Med; 2019 Aug; 19(1):156. PubMed ID: 31438923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-onset meningitis associated with atezolizumab treatment for non-small cell lung cancer: case report and literature review.
    Ogawa K; Kaneda H; Kawamoto T; Tani Y; Izumi M; Matsumoto Y; Sawa K; Suzumura T; Watanabe T; Mitsuoka S; Asai K; Kawaguchi T
    Invest New Drugs; 2020 Dec; 38(6):1901-1905. PubMed ID: 32399862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.